The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: A nationwide survey

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 1, 2013, Pages 56-64

  Gheorghe, Liana ^a   Csiki, Irma E ^b   Iacob, Speranta ^a   Gheorghe, Cristian ^a  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Romania)

Author keywords

Epidemiology; Hepatitis B virus infection; Prevalence; Risk factors

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ALCOHOL CONSUMPTION; BLOOD TRANSFUSION; FEMALE; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ROMANIA; SEROPREVALENCE; SURGICAL TECHNIQUE; TATTOO; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RECURRENCE; RESIDENCE CHARACTERISTICS; RISK FACTORS; ROMANIA; SEX FACTORS; SURGICAL PROCEDURES, OPERATIVE; TATTOOING; YOUNG ADULT;

EID: 84870875581     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328358b0bb     Document Type: Review

References (29)

1. Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, Cavaleri M, et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference. J Viral Hepat 2011; 18 (Suppl. 1):1-16.
2. Rantala M, van de Laar MJW. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Eurosurveillance 2008; 13:1-8.
3. Walter S, Thein HH, Amin J, Gidding HF, Ward K, Law MG, et al. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006. J Hepatol 2011; 54:879-886.
4. European Centre for Disease Prevention and Control. Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies. Stockholm: ECDC; 2010.
5. Molnar G, Popa S, Jebeleanu L, Damian C. Study of the prevalence of serological markers of viral hepatitis in the epidemiological anamnesis of the population. Bacteriol Virusol Parazitol Epidemiol 1994; 30:141-149.
6. Grigorescu M, Radu C, Pascu O. Etiological profile of chronic hepatitis and liver cirrhosis in Romania. A multicentre study. Rom J Gastroenterol 2001; 10:199-204.
7. Nardone A, Anastassopoulou CG, Theeten H, Kriz B, Davidkin I, Thierfelder W, et al. A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect 2009; 137:961-969.
8. Paquet C, Babes VT, Drucker J, Sénémaud B, Dobrescu A. Viral hepatitis in Bucharest. Bull World Health Organ 1993; 71:781-786.
9. Amin J, Gidding HF, Gilbert GL, Backhouse J, Kaldor J, Dore G, et al. Hepatitis C prevalence-a nationwide serosurvey. Commun Dis Intell 2004; 28:517-521.
10. Alter MJ, Kruszon-Moran D, Nainan OU, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-562.
11. Gogos CA, Fouka KP, Nikiforidis G, Avgeridis K, Sakellaropoulos G, Bassaris H, et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol 2003; 18:551-557.
12. Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, Amante A, et al. Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town. Hepatology 2005; 41:1151-1159.
13. Termorshuizen F, Dorigo-Zetsma JW, de Melker HE, van den Hof S, Conyn-Van Spaendonk MA. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population based survey. Epidemiol Infect 2000; 124:459-466.
14. Gidding H. Australia's national seropresurveillance program. NCW Public Health Bull 2003; 14:90-93.
15. Mahoney FJ, Kane M. Hepatitis B vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia: W. B.Saunders & Co.; 2004. pp. 707-743.
16. Roure C. Overview of epidemiology and disease burden of hepatitis B in the European region. Vaccine 1995; 13:S18-S21.
17. Sheikh MY, Mouanoutoua M, Walvick MD, Khang L, Singh J, Stoltz S, et al. Prevalence of hepatitis B virus (HBV) infection among Hmong immigrants in the San Joaquin Valley. J Community Health 2011; 36:42-46.
18. Shen LP, Zhang Y, Wang F, Zhang S, Yang JY, Fang KX, et al. Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme. Epidemiol Infect 2011; 139:1159-1165.
19. Fisker N, Mygind L, Krarup H, Licht D, Georgsen J, Christensen PB. Blood borne viral infections among Danish health care workers - frequent blood exposure but low prevalence of exposure. Eur J Epidemiol 2004; 19:61-67.
20. Liang SH, Chen TJ, Lee SS, Tseng FC, Huang CK, Lai CH, et al. Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection. J Acquir Immune Defic Syndr 2010; 54:122-128.
21. Veldhuijzen IK, Smits LJM, van de Laar MJW. The importance of imported infections in maintaining hepatitis B in The Netherlands. Epidemiol Infect 2005; 133:113-119.
22. Ali SA, Donahue R, Qureshi H, Vermund S. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 2009; 13:9-19.
23. Ammon A, Reichart P, Pauli G, Petersen IR. Hepatitis B and C among Berlin dental personnel: incidence, risk factors, and effectiveness of barrier prevention measures. Epidemiol Infect 2000; 125:407-413.
24. Shepard C, Simard E, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28:112-125.
25. Atanasova MV, Haydouchka IA, Zlatev SP, Stoilova YD, Iliev YT, Mateva NG. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study. Minerva Gastroenterol Dietol 2004; 50:89-96.
26. Carvalho-Filho RJ, de Lucca Schiavon L, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Gomez Ferraz ML, et al. Clinical and histological impact of previous hepatitis B virus infection in patients with chronic hepatitis C. Liver Int 2009; 29:133-140.
27. Dounias G, Kypraiou E, Rachiotis G, Tsovili E, Kostopoulos S. Prevalence of hepatitis B virus markers in municipal solid waste workers in Keratsini (Greece). Occup Med 2005; 55:60-63.
28. Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010; 202:192-202.
29. Grzegorzewska AE, Kurzawska-Firlej D, Ratajewski W, Frankiewicz D, Niepolski L, Kaczmarek A. Antibodies to core antigen of hepatitis B virus in patients on renal replacement therapy: association with demographic, clinical and laboratory data. Nephron Clin Pract 2010; 114:c194-c203.